Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.(QUIT)股票分析

$6.060

-0.249 (-4.11%)收盤時

Loading chart…
最高
6.330
開盤
6.160
成交量加權均價
6.14
成交量
822.53K
市值
—
最低
6.037
成交金額
5.05M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

AI 分析 of Achieve Life Sciences, Inc. (QUIT)

買進

BDJ is a good buy right now due to its attractive 8.1% dividend yield and a solid 32% increase in dividends over the past decade, indicating strong income potential. Additionally, it is currently trading at an 8.2% discount, which could lead to price appreciation as market confidence improves. The main risk is its recent performance with a 1-day change of -0.31%, suggesting some short-term volatility.

估值指標

Achieve Life Sciences, Inc.(QUIT)目前預期本益比為 0.00,5 年平均預期本益比為 。

預期本益比

5 年均值 P/E
目前P/E
0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA
目前EV/EBITDA
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
20.19
目前P/S
20.19
高估
20.19
低估
20.19

持有 QUIT 的大戶

T

TPG Capital, L.P.

+ 持有QUIT

+27.03%

3個月報酬率

L

Logos Global Management, L.P.

+ 持有QUIT

+24.07%

3個月報酬率

P

Paradigm Biocapital Advisors LP

+ 持有QUIT

+19.24%

3個月報酬率

F

Frazier Life Sciences Management, LP

+ 持有QUIT

+10.54%

3個月報酬率

V

VR Management, LLC

+ 持有QUIT

+9.81%

3個月報酬率

QUIT 常見問題 —— 由 Alphio AI 解答

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

BDJ is a good buy right now due to its attractive 8.1% dividend yield and a solid 32% increase in dividends over the past decade, indicating strong income potential. Additionally, it is currently trading at an 8.2% discount, which could lead to price appreciation as market confidence improves. The main risk is its recent performance with a 1-day change of -0.31%, suggesting some short-term volatility.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易